Eli Lilly makes transparency vow

Eli Lilly

With all the talk about big pharma paying physicians for this or that, Eli Lilly is taking on the role of industry forerunner. In a proactive move, the pharma giant says it will start to become transparent about just how much cash it doles out to physicians and for what purpose.

Perhaps with more and more members of Congress setting a disclosure bill in motion, Lilly decided to come face to face with what might be inevitable. Regardless of what happens, it's a decent PR move and pharma companies definitely need good PR these days.   

Specifically, Lilly will disclose how much it pays individual physicals for advisory roles, speeches and other services, as long as the payments are more than $500. The listing will be on a public database. However, Lilly will not be disclosing payments to physicians for travel, gifts and entertainment at this time. 

- here's Lilly's release


Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.